Literature DB >> 21629235

Painful diabetic neuropathy--new choice of first-line therapy?

Nicholas K Tentolouris.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21629235     DOI： 10.1038/nrendo.2011.93

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN： 1759-5029            Impact factor:   43.330


× No keyword cloud information.
  9 in total

Review 1.  Clinical practice. Painful sensory neuropathy.

Authors:  Jerry R Mendell; Zarife Sahenk
Journal:  N Engl J Med       Date:  2003-03-27       Impact factor: 91.245

Review 2.  Diabetic neuropathies: a statement by the American Diabetes Association.

Authors:  Andrew J M Boulton; Arthur I Vinik; Joseph C Arezzo; Vera Bril; Eva L Feldman; Roy Freeman; Rayaz A Malik; Raelene E Maser; Jay M Sosenko; Dan Ziegler
Journal:  Diabetes Care       Date:  2005-04       Impact factor: 19.112

Review 3.  Evidence-based guideline: Treatment of painful diabetic neuropathy: report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation.

Authors:  V Bril; J England; G M Franklin; M Backonja; J Cohen; D Del Toro; E Feldman; D J Iverson; B Perkins; J W Russell; D Zochodne
Journal:  Neurology       Date:  2011-04-11       Impact factor: 9.910

Review 4.  EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision.

Authors:  N Attal; G Cruccu; R Baron; M Haanpää; P Hansson; T S Jensen; T Nurmikko
Journal:  Eur J Neurol       Date:  2010-04-09       Impact factor: 6.089

5.  Clinical characteristics and pain management among patients with painful peripheral neuropathic disorders in general practice settings.

Authors:  Mugdha Gore; Ellen Dukes; David J Rowbotham; Kei-Sing Tai; Douglas Leslie
Journal:  Eur J Pain       Date:  2006-11-27       Impact factor: 3.931

Review 6.  Painful diabetic neuropathy: epidemiology, natural history, early diagnosis, and treatment options.

Authors:  Aristidis Veves; Miroslav Backonja; Rayaz A Malik
Journal:  Pain Med       Date:  2008-09       Impact factor: 3.750

7.  Chronic painful peripheral neuropathy in an urban community: a controlled comparison of people with and without diabetes.

Authors:  C Daousi; I A MacFarlane; A Woodward; T J Nurmikko; P E Bundred; S J Benbow
Journal:  Diabet Med       Date:  2004-09       Impact factor: 4.359

Review 8.  Effects of treatments for symptoms of painful diabetic neuropathy: systematic review.

Authors:  Man-chun Wong; Joanne W Y Chung; Thomas K S Wong
Journal:  BMJ       Date:  2007-06-11

9.  Natural history of peripheral neuropathy in patients with non-insulin-dependent diabetes mellitus.

Authors:  J Partanen; L Niskanen; J Lehtinen; E Mervaala; O Siitonen; M Uusitupa
Journal:  N Engl J Med       Date:  1995-07-13       Impact factor: 91.245
  9 in total
  2 in total

1.  Fulranumab for treatment of diabetic peripheral neuropathic pain: A randomized controlled trial.

Authors:  Hao Wang; Gary Romano; Mary Ellen Frustaci; Norm Bohidar; Huizhong Ma; Panna Sanga; Seth Ness; Lucille J Russell; Margaret Fedgchin; Kathleen M Kelly; John Thipphawong
Journal:  Neurology       Date:  2014-07-09       Impact factor: 9.910

2.  SMTP-44D improves diabetic neuropathy symptoms in mice through its antioxidant and anti-inflammatory activities.

Authors:  Ryosuke Shinouchi; Keita Shibata; Terumasa Hashimoto; Shiori Jono; Keiji Hasumi; Koji Nobe
Journal:  Pharmacol Res Perspect       Date:  2020-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.